STSiolta Therapeutics Team
Siolta Therapeutics
Last updated: February 23, 2026
Siolta Therapeutics is a developer of human microbiome therapeutics intended to prevent and treat inflammatory diseases. Biotech Healthcare Medical
Khosla Ventures, $30M Series B in 2020, $120M valuation
Siolta Therapeutics is a developer of human microbiome therapeutics intended to prevent and treat inflammatory diseases. Biotech Healthcare Medical
Khosla Ventures, $30M Series B in 2020, $120M valuation
- Series B • Khosla Ventures, $30M Series B in 2020, $120M valuation
Founder Intelligence Brief: Siolta Therapeutics Team
This profile is built to help readers move from a founder name to decision-ready context. Siolta Therapeutics Team is mapped to Siolta Therapeutics in the Startup category, with current stage context as Series B. The primary operating market is San Francisco Bay Area, California, USA, which connects this profile directly to regional ecosystem pages and related industry hubs.
Funding visibility currently shows $30.00M, with the latest mapped round as Series B (Khosla Ventures, $30M Series B in 2020, $120M valuation). This makes it easier to evaluate growth narrative against capital stage rather than reading isolated updates without baseline context.
For deeper research, combine this founder page with the company profile, company news hub, country newsroom and Startup startup list. This route gives a cleaner picture of execution, market demand, and competitive movement.
Research flow
- Validate company baseline on company intelligence.
- Compare market peers via Startup industry routes and Series B stage pages.
- Track fresh updates in newsroom coverage and signals feed.
Operating context
- Geography: United States directory.
- Stage signal: Series B funding coverage.
- Hiring status: Open Roles.
Related Founders
More founders in Startup.
Want to get featured on 100Xfounder?
Get your founder profile published with verified funding and hiring context.
Related Pillar Pages
Access the country, industry, stage, startup taxonomy, and newsroom routes connected to this founder.
FAQs About Siolta Therapeutics Team
Common questions people ask about this profile.
Who is Siolta Therapeutics Team?
Siolta Therapeutics Team is the founder profile listed on 100Xfounder for Siolta Therapeutics, tracked for market signals, company intelligence, and operator-level context.
What does Siolta Therapeutics do?
Siolta Therapeutics is a developer of human microbiome therapeutics intended to prevent and treat inflammatory diseases. Biotech Healthcare Medical
Where is Siolta Therapeutics based?
Siolta Therapeutics is listed as operating from San Francisco Bay Area, California, USA.
What is the current funding stage of Siolta Therapeutics?
Siolta Therapeutics is currently categorized at Series B on 100Xfounder. Funding signal: Khosla Ventures, $30M Series B in 2020, $120M valuation
What is the latest funding round for Siolta Therapeutics?
The latest tracked round for Siolta Therapeutics is Series B Khosla Ventures, $30M Series B in 2020, $120M valuation. Total tracked rounds: 1.
Is Siolta Therapeutics hiring right now?
Current hiring signal for Siolta Therapeutics: Open Roles.
Is Siolta Therapeutics Team's profile verified?
Yes. Siolta Therapeutics Team's profile is marked as verified on 100Xfounder as of July 23, 2026.
How can I connect with Siolta Therapeutics Team?
You can use the profile action buttons and listed links on 100Xfounder. Contact context is provided with business relevance and profile metadata for www.sioltatherapeutics.com.
What technologies are associated with Siolta Therapeutics?
Siolta Therapeutics is associated with AWS, React, Python, and PostgreSQL based on current profile intelligence.